Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Pharma Marketing Academy

- PMLiVE

Novo Nordisk announces positive results for CagriSema in type 2 diabetes

CagriSema improved weight loss and blood glucose control compared to semaglutide alone across all tested doses

- PMLiVE

TECregen appoints Klaas P Zuideveld as CEO

Zuideveld was most recently CEO of Versameb, and has held senior roles at Caris Life Sciences and Roche

- PMLiVE

Shaping the future of healthcare communications

Introducing the 2026 Communiqué Awards

Cuttsy+Cuttsy employees

Cuttsy+Cuttsy becomes employee owned

Cuttsy+Cuttsy announces its transition to employee ownership, celebrating 15 years of prioritising clients, patients, and its team while continuing under the leadership of founders Caroline Benson and Mathew Cutts.

Cuttsy + Cuttsy

- PMLiVE

Celebrating Excellence in Healthcare Partnerships Awards!

The Awards were sponsored by Inizio, Chase, druid and Robotics AI

- PMLiVE

Indegene appoints Jill DeSimone to Board of Directors

DeSimone was formerly President of US Oncology at Merck

- PMLiVE

Oral health and systemic disease: why they may be more closely linked than we thought

P. gingivalis, a type of bacteria found in the mouth, is linked to autoimmune diseases like rheumatoid arthritis

- PMLiVE

AstraZeneca and Daiichi Sankyo’s Datroway given FDA Priority Review for breast cancer treatment

Approximately 70% of metastatic triple-negative breast cancer patients are ineligible for immunotherapy, creating an unmet medical need

- PMLiVE

With compassion

If we don’t have compassion, we really do need to question what that says about us as individuals and organisations

- PMLiVE

Spyre Therapeutics appoints Kate Tansey Chevlen as Chief Commercial Officer

Tansey Chevlen previously spent over 17 years at Amgen in multiple leadership roles

- PMLiVE

New Webinar: 2026 Engagement Strategies For Modern Pharma

Turn interaction into intelligence! Don’t miss this chance to lead the industry with our free pharma-exclusive webinar!

Impetus Digital

- PMLiVE

UCB releases new data on Bimzelx for hidradenitis suppurativa

The disease affects around 1% of the population in most studied countries

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links